Several Developed Countries Want To “Derail” Transparency Resolution – Civil Society Groups Say 10/05/2019 David Branigan More than 100 civil society organisations and health experts signed on to an open letter yesterday calling out Germany, Sweden, Denmark, the UK and Australia, along with Austria and the United States, as wanting to “derail” and “weaken” the transparency resolution on drug prices and R&D costs. Image Credits: CDDEP. Continue reading -> New Text Of Italian Transparency Proposal Shows North-South Divide Emerging 08/05/2019 David Branigan A new draft text from an informal consultation at the World Health Organization yesterday shows a North-South divide emerging as member states made changes to the proposed resolution on the transparency of drug prices and the costs of research and development (R&D), brought forward by Italy earlier this year, that is slated for discussion at […] Continue reading -> WHO Report On Cancer Medicines Pricing: Detailed Info On Findings 02/05/2019 David Branigan The World Health Organization held an information session with member states and non-state actors last week to present the detailed findings of its 2018 report on cancer medicines pricing. It then posted the 72 detailed slides from the information session on its website. Image Credits: WHO. Continue reading -> Lack Of Funding Takes Major Toll On Ebola Response 01/05/2019 Divya Schlesinger A festering civil conflict fueling rampant fear and distrust has been a major obstacle in the World Health Organization’s efforts to end the Ebola outbreak in the Democratic Republic of Congo (DRC). But now, funding shortages could further cripple the already strained response – unless the global community steps up quickly, Director-General Dr Tedros Adhanom […] Continue reading -> DNDi: “Bench-To-Bedside” Approach Needed For Drug & Vaccine Response To Global Health Crises 18/04/2019 Elaine Ruth Fletcher Global health policymakers need to adopt a “bench-to-bedside” approach to research and development, to ensure that new drugs and vaccines are not only put into the development pipeline, but are also readily available for responding to global health crises such as Ebola, says Michelle Childs of the Drugs for Neglected Diseases Initiative (DNDi). Image Credits: […] Continue reading -> “Dialogue” Highlighted As Way Forward At Closure Of WHO Fair Pricing Forum 15/04/2019 Elaine Ruth Fletcher WHO said that it will launch a public online consultation involving governments, industry and civil society to try to come up with a broad consensus on what actually constitutes a “fair price” for essential medicines. This critical next step was announced Saturday in a WHO press release following the close of the 2nd Fair Pricing […] Continue reading -> Diarrhoea Can Be More Dangerous Than Bullets To Children During Conflicts, Emergencies 29/03/2019 David Branigan In extended conflicts, “bullets and bombs are not always the deadliest threats to a child’s life,” a new UNICEF report reveals. During such conflicts, children are up to 20 times more likely to die from diarrhoea than violence. As is evidenced by recent outbreaks of cholera in Yemen and Mozambique, conflict and disaster-resilient water, sanitation […] Continue reading -> DRC Ebola Response: Need To “Find A Balance” Between Protecting Patients, Building Trust 14/03/2019 David Branigan World Health Organization Director-General Dr Tedros Adhanom Ghebreyesus told reporters today that WHO is “working to find a balance between protecting patients and staff from attacks by armed groups and building community trust and ownership” in managing the response to the deadly Ebola epidemic in the Democratic Republic of Congo. Image Credits: Gabriele François Casini/MSF. Continue reading -> CEPI Board Reaffirms Commitment To Safeguard Access To New Vaccines 08/03/2019 Elaine Ruth Fletcher The Coalition for Epidemic Preparedness Innovations (CEPI), an innovative collaboration of governments, UN agencies, foundations and the private sector, has reaffirmed its commitment to safeguard and promote equitable access to new vaccines under development to head off the risk of disease outbreaks, epidemics and pandemics that threaten global health. Image Credits: CEPI / CureVac. Continue reading -> Strengthening Supply Chain Security For Essential Antimalarial Drugs 28/02/2019 David Branigan Secure and reliable supply chains for life-saving medicines are essential features of the global health landscape. They ensure that quality approved drugs are manufactured and available in the quantities needed, without interruption. For the fight against malaria, securing supply chains for quality, life-saving antimalarials involves the collective effort of a range of organisations working to mitigate the risk of any shortage of these drugs. A recent success in this area has been the quality approval of a second supplier of injectable artesunate, the drug recommended by the World Health Organization to treat severe malaria. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
New Text Of Italian Transparency Proposal Shows North-South Divide Emerging 08/05/2019 David Branigan A new draft text from an informal consultation at the World Health Organization yesterday shows a North-South divide emerging as member states made changes to the proposed resolution on the transparency of drug prices and the costs of research and development (R&D), brought forward by Italy earlier this year, that is slated for discussion at […] Continue reading -> WHO Report On Cancer Medicines Pricing: Detailed Info On Findings 02/05/2019 David Branigan The World Health Organization held an information session with member states and non-state actors last week to present the detailed findings of its 2018 report on cancer medicines pricing. It then posted the 72 detailed slides from the information session on its website. Image Credits: WHO. Continue reading -> Lack Of Funding Takes Major Toll On Ebola Response 01/05/2019 Divya Schlesinger A festering civil conflict fueling rampant fear and distrust has been a major obstacle in the World Health Organization’s efforts to end the Ebola outbreak in the Democratic Republic of Congo (DRC). But now, funding shortages could further cripple the already strained response – unless the global community steps up quickly, Director-General Dr Tedros Adhanom […] Continue reading -> DNDi: “Bench-To-Bedside” Approach Needed For Drug & Vaccine Response To Global Health Crises 18/04/2019 Elaine Ruth Fletcher Global health policymakers need to adopt a “bench-to-bedside” approach to research and development, to ensure that new drugs and vaccines are not only put into the development pipeline, but are also readily available for responding to global health crises such as Ebola, says Michelle Childs of the Drugs for Neglected Diseases Initiative (DNDi). Image Credits: […] Continue reading -> “Dialogue” Highlighted As Way Forward At Closure Of WHO Fair Pricing Forum 15/04/2019 Elaine Ruth Fletcher WHO said that it will launch a public online consultation involving governments, industry and civil society to try to come up with a broad consensus on what actually constitutes a “fair price” for essential medicines. This critical next step was announced Saturday in a WHO press release following the close of the 2nd Fair Pricing […] Continue reading -> Diarrhoea Can Be More Dangerous Than Bullets To Children During Conflicts, Emergencies 29/03/2019 David Branigan In extended conflicts, “bullets and bombs are not always the deadliest threats to a child’s life,” a new UNICEF report reveals. During such conflicts, children are up to 20 times more likely to die from diarrhoea than violence. As is evidenced by recent outbreaks of cholera in Yemen and Mozambique, conflict and disaster-resilient water, sanitation […] Continue reading -> DRC Ebola Response: Need To “Find A Balance” Between Protecting Patients, Building Trust 14/03/2019 David Branigan World Health Organization Director-General Dr Tedros Adhanom Ghebreyesus told reporters today that WHO is “working to find a balance between protecting patients and staff from attacks by armed groups and building community trust and ownership” in managing the response to the deadly Ebola epidemic in the Democratic Republic of Congo. Image Credits: Gabriele François Casini/MSF. Continue reading -> CEPI Board Reaffirms Commitment To Safeguard Access To New Vaccines 08/03/2019 Elaine Ruth Fletcher The Coalition for Epidemic Preparedness Innovations (CEPI), an innovative collaboration of governments, UN agencies, foundations and the private sector, has reaffirmed its commitment to safeguard and promote equitable access to new vaccines under development to head off the risk of disease outbreaks, epidemics and pandemics that threaten global health. Image Credits: CEPI / CureVac. Continue reading -> Strengthening Supply Chain Security For Essential Antimalarial Drugs 28/02/2019 David Branigan Secure and reliable supply chains for life-saving medicines are essential features of the global health landscape. They ensure that quality approved drugs are manufactured and available in the quantities needed, without interruption. For the fight against malaria, securing supply chains for quality, life-saving antimalarials involves the collective effort of a range of organisations working to mitigate the risk of any shortage of these drugs. A recent success in this area has been the quality approval of a second supplier of injectable artesunate, the drug recommended by the World Health Organization to treat severe malaria. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
WHO Report On Cancer Medicines Pricing: Detailed Info On Findings 02/05/2019 David Branigan The World Health Organization held an information session with member states and non-state actors last week to present the detailed findings of its 2018 report on cancer medicines pricing. It then posted the 72 detailed slides from the information session on its website. Image Credits: WHO. Continue reading -> Lack Of Funding Takes Major Toll On Ebola Response 01/05/2019 Divya Schlesinger A festering civil conflict fueling rampant fear and distrust has been a major obstacle in the World Health Organization’s efforts to end the Ebola outbreak in the Democratic Republic of Congo (DRC). But now, funding shortages could further cripple the already strained response – unless the global community steps up quickly, Director-General Dr Tedros Adhanom […] Continue reading -> DNDi: “Bench-To-Bedside” Approach Needed For Drug & Vaccine Response To Global Health Crises 18/04/2019 Elaine Ruth Fletcher Global health policymakers need to adopt a “bench-to-bedside” approach to research and development, to ensure that new drugs and vaccines are not only put into the development pipeline, but are also readily available for responding to global health crises such as Ebola, says Michelle Childs of the Drugs for Neglected Diseases Initiative (DNDi). Image Credits: […] Continue reading -> “Dialogue” Highlighted As Way Forward At Closure Of WHO Fair Pricing Forum 15/04/2019 Elaine Ruth Fletcher WHO said that it will launch a public online consultation involving governments, industry and civil society to try to come up with a broad consensus on what actually constitutes a “fair price” for essential medicines. This critical next step was announced Saturday in a WHO press release following the close of the 2nd Fair Pricing […] Continue reading -> Diarrhoea Can Be More Dangerous Than Bullets To Children During Conflicts, Emergencies 29/03/2019 David Branigan In extended conflicts, “bullets and bombs are not always the deadliest threats to a child’s life,” a new UNICEF report reveals. During such conflicts, children are up to 20 times more likely to die from diarrhoea than violence. As is evidenced by recent outbreaks of cholera in Yemen and Mozambique, conflict and disaster-resilient water, sanitation […] Continue reading -> DRC Ebola Response: Need To “Find A Balance” Between Protecting Patients, Building Trust 14/03/2019 David Branigan World Health Organization Director-General Dr Tedros Adhanom Ghebreyesus told reporters today that WHO is “working to find a balance between protecting patients and staff from attacks by armed groups and building community trust and ownership” in managing the response to the deadly Ebola epidemic in the Democratic Republic of Congo. Image Credits: Gabriele François Casini/MSF. Continue reading -> CEPI Board Reaffirms Commitment To Safeguard Access To New Vaccines 08/03/2019 Elaine Ruth Fletcher The Coalition for Epidemic Preparedness Innovations (CEPI), an innovative collaboration of governments, UN agencies, foundations and the private sector, has reaffirmed its commitment to safeguard and promote equitable access to new vaccines under development to head off the risk of disease outbreaks, epidemics and pandemics that threaten global health. Image Credits: CEPI / CureVac. Continue reading -> Strengthening Supply Chain Security For Essential Antimalarial Drugs 28/02/2019 David Branigan Secure and reliable supply chains for life-saving medicines are essential features of the global health landscape. They ensure that quality approved drugs are manufactured and available in the quantities needed, without interruption. For the fight against malaria, securing supply chains for quality, life-saving antimalarials involves the collective effort of a range of organisations working to mitigate the risk of any shortage of these drugs. A recent success in this area has been the quality approval of a second supplier of injectable artesunate, the drug recommended by the World Health Organization to treat severe malaria. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Lack Of Funding Takes Major Toll On Ebola Response 01/05/2019 Divya Schlesinger A festering civil conflict fueling rampant fear and distrust has been a major obstacle in the World Health Organization’s efforts to end the Ebola outbreak in the Democratic Republic of Congo (DRC). But now, funding shortages could further cripple the already strained response – unless the global community steps up quickly, Director-General Dr Tedros Adhanom […] Continue reading -> DNDi: “Bench-To-Bedside” Approach Needed For Drug & Vaccine Response To Global Health Crises 18/04/2019 Elaine Ruth Fletcher Global health policymakers need to adopt a “bench-to-bedside” approach to research and development, to ensure that new drugs and vaccines are not only put into the development pipeline, but are also readily available for responding to global health crises such as Ebola, says Michelle Childs of the Drugs for Neglected Diseases Initiative (DNDi). Image Credits: […] Continue reading -> “Dialogue” Highlighted As Way Forward At Closure Of WHO Fair Pricing Forum 15/04/2019 Elaine Ruth Fletcher WHO said that it will launch a public online consultation involving governments, industry and civil society to try to come up with a broad consensus on what actually constitutes a “fair price” for essential medicines. This critical next step was announced Saturday in a WHO press release following the close of the 2nd Fair Pricing […] Continue reading -> Diarrhoea Can Be More Dangerous Than Bullets To Children During Conflicts, Emergencies 29/03/2019 David Branigan In extended conflicts, “bullets and bombs are not always the deadliest threats to a child’s life,” a new UNICEF report reveals. During such conflicts, children are up to 20 times more likely to die from diarrhoea than violence. As is evidenced by recent outbreaks of cholera in Yemen and Mozambique, conflict and disaster-resilient water, sanitation […] Continue reading -> DRC Ebola Response: Need To “Find A Balance” Between Protecting Patients, Building Trust 14/03/2019 David Branigan World Health Organization Director-General Dr Tedros Adhanom Ghebreyesus told reporters today that WHO is “working to find a balance between protecting patients and staff from attacks by armed groups and building community trust and ownership” in managing the response to the deadly Ebola epidemic in the Democratic Republic of Congo. Image Credits: Gabriele François Casini/MSF. Continue reading -> CEPI Board Reaffirms Commitment To Safeguard Access To New Vaccines 08/03/2019 Elaine Ruth Fletcher The Coalition for Epidemic Preparedness Innovations (CEPI), an innovative collaboration of governments, UN agencies, foundations and the private sector, has reaffirmed its commitment to safeguard and promote equitable access to new vaccines under development to head off the risk of disease outbreaks, epidemics and pandemics that threaten global health. Image Credits: CEPI / CureVac. Continue reading -> Strengthening Supply Chain Security For Essential Antimalarial Drugs 28/02/2019 David Branigan Secure and reliable supply chains for life-saving medicines are essential features of the global health landscape. They ensure that quality approved drugs are manufactured and available in the quantities needed, without interruption. For the fight against malaria, securing supply chains for quality, life-saving antimalarials involves the collective effort of a range of organisations working to mitigate the risk of any shortage of these drugs. A recent success in this area has been the quality approval of a second supplier of injectable artesunate, the drug recommended by the World Health Organization to treat severe malaria. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
DNDi: “Bench-To-Bedside” Approach Needed For Drug & Vaccine Response To Global Health Crises 18/04/2019 Elaine Ruth Fletcher Global health policymakers need to adopt a “bench-to-bedside” approach to research and development, to ensure that new drugs and vaccines are not only put into the development pipeline, but are also readily available for responding to global health crises such as Ebola, says Michelle Childs of the Drugs for Neglected Diseases Initiative (DNDi). Image Credits: […] Continue reading -> “Dialogue” Highlighted As Way Forward At Closure Of WHO Fair Pricing Forum 15/04/2019 Elaine Ruth Fletcher WHO said that it will launch a public online consultation involving governments, industry and civil society to try to come up with a broad consensus on what actually constitutes a “fair price” for essential medicines. This critical next step was announced Saturday in a WHO press release following the close of the 2nd Fair Pricing […] Continue reading -> Diarrhoea Can Be More Dangerous Than Bullets To Children During Conflicts, Emergencies 29/03/2019 David Branigan In extended conflicts, “bullets and bombs are not always the deadliest threats to a child’s life,” a new UNICEF report reveals. During such conflicts, children are up to 20 times more likely to die from diarrhoea than violence. As is evidenced by recent outbreaks of cholera in Yemen and Mozambique, conflict and disaster-resilient water, sanitation […] Continue reading -> DRC Ebola Response: Need To “Find A Balance” Between Protecting Patients, Building Trust 14/03/2019 David Branigan World Health Organization Director-General Dr Tedros Adhanom Ghebreyesus told reporters today that WHO is “working to find a balance between protecting patients and staff from attacks by armed groups and building community trust and ownership” in managing the response to the deadly Ebola epidemic in the Democratic Republic of Congo. Image Credits: Gabriele François Casini/MSF. Continue reading -> CEPI Board Reaffirms Commitment To Safeguard Access To New Vaccines 08/03/2019 Elaine Ruth Fletcher The Coalition for Epidemic Preparedness Innovations (CEPI), an innovative collaboration of governments, UN agencies, foundations and the private sector, has reaffirmed its commitment to safeguard and promote equitable access to new vaccines under development to head off the risk of disease outbreaks, epidemics and pandemics that threaten global health. Image Credits: CEPI / CureVac. Continue reading -> Strengthening Supply Chain Security For Essential Antimalarial Drugs 28/02/2019 David Branigan Secure and reliable supply chains for life-saving medicines are essential features of the global health landscape. They ensure that quality approved drugs are manufactured and available in the quantities needed, without interruption. For the fight against malaria, securing supply chains for quality, life-saving antimalarials involves the collective effort of a range of organisations working to mitigate the risk of any shortage of these drugs. A recent success in this area has been the quality approval of a second supplier of injectable artesunate, the drug recommended by the World Health Organization to treat severe malaria. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
“Dialogue” Highlighted As Way Forward At Closure Of WHO Fair Pricing Forum 15/04/2019 Elaine Ruth Fletcher WHO said that it will launch a public online consultation involving governments, industry and civil society to try to come up with a broad consensus on what actually constitutes a “fair price” for essential medicines. This critical next step was announced Saturday in a WHO press release following the close of the 2nd Fair Pricing […] Continue reading -> Diarrhoea Can Be More Dangerous Than Bullets To Children During Conflicts, Emergencies 29/03/2019 David Branigan In extended conflicts, “bullets and bombs are not always the deadliest threats to a child’s life,” a new UNICEF report reveals. During such conflicts, children are up to 20 times more likely to die from diarrhoea than violence. As is evidenced by recent outbreaks of cholera in Yemen and Mozambique, conflict and disaster-resilient water, sanitation […] Continue reading -> DRC Ebola Response: Need To “Find A Balance” Between Protecting Patients, Building Trust 14/03/2019 David Branigan World Health Organization Director-General Dr Tedros Adhanom Ghebreyesus told reporters today that WHO is “working to find a balance between protecting patients and staff from attacks by armed groups and building community trust and ownership” in managing the response to the deadly Ebola epidemic in the Democratic Republic of Congo. Image Credits: Gabriele François Casini/MSF. Continue reading -> CEPI Board Reaffirms Commitment To Safeguard Access To New Vaccines 08/03/2019 Elaine Ruth Fletcher The Coalition for Epidemic Preparedness Innovations (CEPI), an innovative collaboration of governments, UN agencies, foundations and the private sector, has reaffirmed its commitment to safeguard and promote equitable access to new vaccines under development to head off the risk of disease outbreaks, epidemics and pandemics that threaten global health. Image Credits: CEPI / CureVac. Continue reading -> Strengthening Supply Chain Security For Essential Antimalarial Drugs 28/02/2019 David Branigan Secure and reliable supply chains for life-saving medicines are essential features of the global health landscape. They ensure that quality approved drugs are manufactured and available in the quantities needed, without interruption. For the fight against malaria, securing supply chains for quality, life-saving antimalarials involves the collective effort of a range of organisations working to mitigate the risk of any shortage of these drugs. A recent success in this area has been the quality approval of a second supplier of injectable artesunate, the drug recommended by the World Health Organization to treat severe malaria. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Diarrhoea Can Be More Dangerous Than Bullets To Children During Conflicts, Emergencies 29/03/2019 David Branigan In extended conflicts, “bullets and bombs are not always the deadliest threats to a child’s life,” a new UNICEF report reveals. During such conflicts, children are up to 20 times more likely to die from diarrhoea than violence. As is evidenced by recent outbreaks of cholera in Yemen and Mozambique, conflict and disaster-resilient water, sanitation […] Continue reading -> DRC Ebola Response: Need To “Find A Balance” Between Protecting Patients, Building Trust 14/03/2019 David Branigan World Health Organization Director-General Dr Tedros Adhanom Ghebreyesus told reporters today that WHO is “working to find a balance between protecting patients and staff from attacks by armed groups and building community trust and ownership” in managing the response to the deadly Ebola epidemic in the Democratic Republic of Congo. Image Credits: Gabriele François Casini/MSF. Continue reading -> CEPI Board Reaffirms Commitment To Safeguard Access To New Vaccines 08/03/2019 Elaine Ruth Fletcher The Coalition for Epidemic Preparedness Innovations (CEPI), an innovative collaboration of governments, UN agencies, foundations and the private sector, has reaffirmed its commitment to safeguard and promote equitable access to new vaccines under development to head off the risk of disease outbreaks, epidemics and pandemics that threaten global health. Image Credits: CEPI / CureVac. Continue reading -> Strengthening Supply Chain Security For Essential Antimalarial Drugs 28/02/2019 David Branigan Secure and reliable supply chains for life-saving medicines are essential features of the global health landscape. They ensure that quality approved drugs are manufactured and available in the quantities needed, without interruption. For the fight against malaria, securing supply chains for quality, life-saving antimalarials involves the collective effort of a range of organisations working to mitigate the risk of any shortage of these drugs. A recent success in this area has been the quality approval of a second supplier of injectable artesunate, the drug recommended by the World Health Organization to treat severe malaria. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
DRC Ebola Response: Need To “Find A Balance” Between Protecting Patients, Building Trust 14/03/2019 David Branigan World Health Organization Director-General Dr Tedros Adhanom Ghebreyesus told reporters today that WHO is “working to find a balance between protecting patients and staff from attacks by armed groups and building community trust and ownership” in managing the response to the deadly Ebola epidemic in the Democratic Republic of Congo. Image Credits: Gabriele François Casini/MSF. Continue reading -> CEPI Board Reaffirms Commitment To Safeguard Access To New Vaccines 08/03/2019 Elaine Ruth Fletcher The Coalition for Epidemic Preparedness Innovations (CEPI), an innovative collaboration of governments, UN agencies, foundations and the private sector, has reaffirmed its commitment to safeguard and promote equitable access to new vaccines under development to head off the risk of disease outbreaks, epidemics and pandemics that threaten global health. Image Credits: CEPI / CureVac. Continue reading -> Strengthening Supply Chain Security For Essential Antimalarial Drugs 28/02/2019 David Branigan Secure and reliable supply chains for life-saving medicines are essential features of the global health landscape. They ensure that quality approved drugs are manufactured and available in the quantities needed, without interruption. For the fight against malaria, securing supply chains for quality, life-saving antimalarials involves the collective effort of a range of organisations working to mitigate the risk of any shortage of these drugs. A recent success in this area has been the quality approval of a second supplier of injectable artesunate, the drug recommended by the World Health Organization to treat severe malaria. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
CEPI Board Reaffirms Commitment To Safeguard Access To New Vaccines 08/03/2019 Elaine Ruth Fletcher The Coalition for Epidemic Preparedness Innovations (CEPI), an innovative collaboration of governments, UN agencies, foundations and the private sector, has reaffirmed its commitment to safeguard and promote equitable access to new vaccines under development to head off the risk of disease outbreaks, epidemics and pandemics that threaten global health. Image Credits: CEPI / CureVac. Continue reading -> Strengthening Supply Chain Security For Essential Antimalarial Drugs 28/02/2019 David Branigan Secure and reliable supply chains for life-saving medicines are essential features of the global health landscape. They ensure that quality approved drugs are manufactured and available in the quantities needed, without interruption. For the fight against malaria, securing supply chains for quality, life-saving antimalarials involves the collective effort of a range of organisations working to mitigate the risk of any shortage of these drugs. A recent success in this area has been the quality approval of a second supplier of injectable artesunate, the drug recommended by the World Health Organization to treat severe malaria. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Strengthening Supply Chain Security For Essential Antimalarial Drugs 28/02/2019 David Branigan Secure and reliable supply chains for life-saving medicines are essential features of the global health landscape. They ensure that quality approved drugs are manufactured and available in the quantities needed, without interruption. For the fight against malaria, securing supply chains for quality, life-saving antimalarials involves the collective effort of a range of organisations working to mitigate the risk of any shortage of these drugs. A recent success in this area has been the quality approval of a second supplier of injectable artesunate, the drug recommended by the World Health Organization to treat severe malaria. Continue reading -> Posts navigation Older postsNewer posts